Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells

Journal of Gene Medicine

Volumn 12, Issue 12, 2010, Pages 945-955

  Zhang, Xia ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

ABCG2; CD133; Hematopoietic progenitor cells; Human cord blood; Sindbis Env pseudotyped lentiviral particles; Targeted viral entry

Indexed keywords

ANTIBODY; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CHOLESTEROL; HLA A1 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL LINEAGE; CELL SURFACE; CONJUGATION; CONTROLLED STUDY; FEASIBILITY STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PSEUDOTYPING; SINDBIS VIRUS; UMBILICAL CORD BLOOD; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE;

ANTIBODIES; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; DRUG DELIVERY SYSTEMS; FETAL BLOOD; GENE THERAPY; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; NEOPLASM PROTEINS; PEPTIDES; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

SINDBIS VIRUS;

EID: 78650026913     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1518     Document Type: Article

References (54)

1. Han X, Kasahara N, Kan YW. Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 1995; 92: 9747-9751.
2. Sarangi A, Bupp K, Roth MJ. Identification of a retroviral receptor used by an envelope protein derived by peptide library screening. Proc Natl Acad Sci USA 2007; 104: 11032-11037.
3. Bupp K, Roth MJ. Targeting a retroviral vector in the absence of a known cell-targeting ligand. Hum Gene Ther 2003; 14: 1557-1564.
4. Bupp K, Sarangi A, Roth MJ. Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries. J Virol 2005; 79: 1463-1469.
5. Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci USA 1995; 92: 7570-7574.
6. Jiang A, Dornburg R. In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies. Gene Ther 1999; 6: 1982-1987.
7. Marin M, Noel D, Valsesia-Wittman S, et al. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J Virol 1996; 70: 2957-2962.
8. Solly SK, Nguyen TH, Weber A, et al. Targeting of c-Met and urokinase expressing human glioma cell lines by retrovirus vector displaying single-chain variable fragment antibody. Cancer Biol Ther 2005; 4: 987-992.
9. Aires da Silva F, Costa MJ, Corte-Real S, et al. Cell type-specific targeting with Sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies. Hum Gene Ther 2005; 16: 223-234.
10. Lee H, Song JJ, Kim E, et al. Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor. Gene Ther 2001; 8: 268-273.
11. Ricks DM, Kutner R, Zhang XY, et al. Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2008; 17: 441-450.
12. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994; 58: 491-562.
13. Bredenbeek PJ, Frolov I, Rice CM, et al. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol 1993; 67: 6439-6446.
14. Liljestrom P, Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 1991; 9: 1356-1361.
15. Morizono K, Xie Y, Ringpis GE, et al. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 2005; 11: 346-352.
16. Xiong C, Levis R, Shen P, et al. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 1989; 243: 1188-1191.
17. Yang L, Bailey L, Baltimore D, et al. Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA 2006; 103: 11479-11484.
18. Ziegler L, Yang L, Joo KI, et al. Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum Gene Ther 2008; 19: 861-872.
19. Liang M, Pariente N, Morizono K, et al. Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells. J Gene Med 2009; 11: 185-196.
20. Wang KS, Kuhn RJ, Strauss EG, et al. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 1992; 66: 4992-5001.
21. Klimstra WB, Ryman KD, Johnston RE. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 1998; 72: 7357-7366.
22. Klimstra WB, Nangle EM, Smith MS, et al. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol 2003; 77: 12022-12032.
23. Morizono K, Xie Y, Helguera G, et al. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. J Gene Med 2009; 11: 655-663.
24. Ohno K, Sawai K, Iijima Y, et al. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol 1997; 15: 763-767.
25. Lu YE, Cassese T, Kielian M. The cholesterol requirement for Sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol 1999; 73: 4272-4278.
26. Pariente N, Morizono K, Virk MS, et al. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther 2007; 15: 1973-1981.
27. Pariente N, Mao S, Morizono K, et al. Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J Gene Med 2008; 10: 242-248.
28. Zanjani ED, Almeida-Porada G, Livingston AG, et al. Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol 2003; 31: 406-412.
29. Guo Y, Lubbert M, Engelhardt M. CD34-hematopoietic stem cells: current concepts and controversies. Stem Cells 2003; 21: 15-20.
30. Osawa M, Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic cell. Science 1996; 273: 242-245.
31. Wang J, Kimura T, Asada R, et al. SCID-repopulating cell activity of human cord blood-derived CD34-cells assured by intra-bone marrow injection. Blood 2003; 101: 2924-2931.
32. Tadjali M, Zhou S, Rehg J, et al. Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele. Stem Cells 2006; 24: 1556-1563.
33. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028-1034.
34. Ahmed F, Arseni N, Glimm H, et al. Constitutive expression of the ATP-binding cassette transporter ABCG2 enhances the growth potential of early human hematopoietic progenitors. Stem Cells 2008; 26: 810-818.
35. Yin A, Miraglia S, Zanjani E, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
36. Miraglia S, Godfrey W, Yin A, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 15: 5013-5021.
37. Morizono K, Ringpis GE, Pariente N, et al. Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope. Virology 2006; 355: 71-81.
38. Zufferey R, Donello JE, Trono D, et al. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886-2892.
39. Mukherjee S, Lee H-LR, Pacchia AL, et al. A HIV-2-based self-inactivating vector for enhanced gene transduction. J Biotechnol 2007; 127: 745-757.
40. Loewen N, Bahler C, Teo W-l, et al. Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest Ophthalmol Vis Sci 2002; 43: 3686-3690.
41. Saenz DT, Poeschla EM. FIV: from lentivirus to lentivector. J Gene Med 2004; 6: S95-S104.
42. Hober S, Nord K, Linhult M. Protein A chromatography for antibody purification. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 848: 40-47.
43. Sastry L, Xu Y, Cooper R, et al. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment. Hum Gene Ther 2004; 15: 221-226.
44. Christensen J, Weissman I. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA 2001; 98: 14541-14546.
45. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991; 174: 63-71.
46. Bhatia M. AC133 expression in human stem cells. Leukemia 2001; 15: 1685-1688.
47. Mizokami T, Hisha H, Okazaki S, et al. Preferential expansion of human umbilical cord blood-derived CD34-positive cells on major histocompatibility complex-matched amnion-derived mesenchymal stem cells. Haematologica 2009; 94: 618-628.
48. DeTulleo L, Kirchhausen T. The clathrin endocytic pathway in viral infection. EMBO J 1998; 17: 4585-4593.
49. Kielian M. Membrane fusion and the alphavirus life cycle. Adv Virus Res 1995; 45: 113-151.
50. Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806.
51. Naylor CS, Jaworska E, Branson K, et al. Side population/ABCG2-positive cells represent a heterogeneous group of haemopoietic cells: implications for the use of adult stem cells in transplantation and plasticity protocols. Bone Marrow Transplant 2005; 35: 353-360.
52. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207-6219.
53. Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006; 44: 240-251.
54. Chan EM, Ratanasirintrawoot S, Park I-H, et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009; 27: 1033-1037.